» Articles » PMID: 32127904

Carcinoma Ex Pleomorphic Adenoma: a Case Report and Review of Literature

Overview
Journal Afr Health Sci
Date 2020 Mar 5
PMID 32127904
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carcinoma ex pleomorphic adenoma (CA-ex-PA) is extremely unusual in minor salivary glands of oral cavity. CAex-PA is a carcinomatous change as a primary or as a recurrence of pleomorphic adenoma.

Objective: Due to resemblance of clinical symptoms of Ca ex PA and benign pleomorphic adenoma, it is mandatory for surgeons to keep high degree of clinical alertness, considering the peculiarity of this tumor.

Case Report: 54-year-old male presented with swelling on left side in the pre-auricular region from the middle of zygomatic arch to mastoid process and from tragus of the ear up to angle of mandible. Fine needle aspiration cytology revealed a mixture of benign and malignant components. Total left parotidectomy with left radical neck dissection followed by reconstruction with cervicodeltopectoral flap was performed. Combination of chemotherapy and radiotherapy were given to patient. Histologic examination and pre-operative fine needle aspiration cytology confirmed the diagnosis of Carcinoma ex pleomorphic adenoma (CA-ex-PA). Two-year follow-up of patient showed no recurrence of the lesion.

Conclusion: Due to the similarity in the clinical symptoms of CA-ex-PA and benign pleomorphic adenoma, it is vital that clinicians maintain a high degree of clinical vigilance, considering the oddity of this malignancy.

Citing Articles

Deep learning based ultrasound analysis facilitates precise distinction between parotid pleomorphic adenoma and Warthin tumor.

Liu X, Miao Y, Qian L, Shi Z, Wang Y, Su J Front Oncol. 2024; 14:1337631.

PMID: 38476360 PMC: 10927830. DOI: 10.3389/fonc.2024.1337631.


FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma.

Pikul J, Rzepakowska A, Machnicki M, Stoklosa T Contemp Oncol (Pozn). 2024; 27(3):211-216.

PMID: 38239864 PMC: 10793617. DOI: 10.5114/wo.2023.133592.


A Rare Case of Carcinoma Ex-pleomorphic Adenoma.

Reddy R J Microsc Ultrastruct. 2024; 11(4):245-247.

PMID: 38213649 PMC: 10779441. DOI: 10.4103/jmau.jmau_129_20.


The Usefulness of Fine Needle Aspiration Cytology in the Management of Parotid Gland Masses at a Tertiary Academic Hospital.

Mdletshe F, Luvhengo T, Masege D Indian J Otolaryngol Head Neck Surg. 2023; 75(4):3199-3204.

PMID: 38027536 PMC: 10646002. DOI: 10.1007/s12070-023-03685-6.


Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma.

Magalhaes I, Barbosa K, Costa G, de Oliveira Filho O, Erialdo da Silva Junior J, Gonzaga Silva L Asian Pac J Cancer Prev. 2023; 24(11):3815-3824.

PMID: 38019239 PMC: 10772772. DOI: 10.31557/APJCP.2023.24.11.3815.


References
1.
Ethunandan M, Witton R, Hoffman G, Spedding A, Brennan P . Atypical features in pleomorphic adenoma--a clinicopathologic study and implications for management. Int J Oral Maxillofac Surg. 2006; 35(7):608-12. DOI: 10.1016/j.ijom.2006.02.009. View

2.
Livolsi V, Perzin K . Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977; 39(5):2209-30. DOI: 10.1002/1097-0142(197705)39:5<2209::aid-cncr2820390540>3.0.co;2-8. View

3.
Luers J, Wittekindt C, Streppel M, Guntinas-Lichius O . Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol. 2008; 48(1):132-6. DOI: 10.1080/02841860802183604. View

4.
Mitate E, Kawano S, Kiyoshima T, Kawazu T, Chikui T, Goto Y . Carcinoma ex pleomorphic adenoma of the upper lip: a case of an unusual malignant component of squamous cell carcinoma. World J Surg Oncol. 2013; 11:234. PMC: 3849529. DOI: 10.1186/1477-7819-11-234. View

5.
Prabhu S, Kaveri H, Rekha K . Benign, malignant salivary gland tumors: comparison of immunohistochemical expression of e-cadherin. Oral Oncol. 2008; 45(7):594-9. DOI: 10.1016/j.oraloncology.2008.08.004. View